Unstable angina pectoris
Conditions
Interventions
Trial Group:Placebo groupconventional therapycombine with Qing-Xin-Jie-Yu Granule
Placebo group:conventional therapycombine with paceDo
Sponsors
Xiyuan Hospital China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1)35 years = age =75 years 2)The diagnostic criteria of unstable angina were met 3)The syndrome differentiation of TCM belongs to the syndrome of stasis and toxin 4)hs-CRP=2mg/L 5)Volunteer and sign the informed consent form
Exclusion criteria
Exclusion criteria: Anyone who meets any of the following conditions will be excluded: 1)Individuals with heart diseases caused by conditions other than coronary artery disease such as primary cardiomyopathy or infective endocarditis. 2)Individuals who have had infections fever trauma burns or surgeries within the past month. 3)Individuals with a tendency to bleed or low platelet count. 4)Individuals currently using antibiotics or traditional Chinese medicine for clearing heat and detoxification. 5)Individuals with severe heart failure and left ventricular ejection fraction (LVEF) < 50%. 6)Individuals with malignant arrhythmias (paroxysmal ventricular tachycardia) who have had frequent recent episodes. 7)Individuals with malignant tumors active autoimmune diseases or tuberculosis. 8)Pregnant women women planning pregnancy or breastfeeding women. 9)Individuals who have participated in other clinical trials within the past month or individuals with expected poor compliance or individuals allergic to the components of the trial medication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hs-CRP; | — |
Secondary
| Measure | Time frame |
|---|---|
| Levels of other inflammatory factors;Cardiac function parameters;brain natriuretic peptide;Seattle Angina Questionnaire;Adverse cardiovascular events; | — |
Countries
China
Contacts
Public ContactHao Xu
Xiyuan Hospital China Academy of Chinese Medical Sciences
Outcome results
None listed